By the time you have showered, dressed, and prepared for the day, the 30 minutes have passed and coffee is ready
#Pharma #GLP1 #ObesityTreatment #DrugDevelopment #HealthcareInnovation #EliLilly #NovoNordisk #PharmaceuticalIndustry To view or add a comment, sign in NEW DRUG APPROVAL ALERT The FDA has approved Foundayo (orforglipron), a new once-daily oral GLP-1 for chronic weight management in adults with obesity, or adults with overweight plus at least one weight-related condition
41,42 GLP-1R is expressed in the cardiovascular system, and its knockout has implications for cardiovascular function
Most patients restart at a low introductory dose when switching GLP-1 medications to limit side effects
Endocrinology (2018) 159:195063
Additionally, its important to discuss any other medications you may be taking with the prescribing healthcare professional